Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis
Z Shubber, EJ Mills, JB Nachega, R Vreeman… - PLoS …, 2016 - journals.plos.org
Background Maintaining high levels of adherence to antiretroviral therapy (ART) is a
challenge across settings and populations. Understanding the relative importance of …
challenge across settings and populations. Understanding the relative importance of …
Depression and adherence to antiretroviral therapy in low-, middle-and high-income countries: a systematic review and meta-analysis
We investigated the associations between depressive symptoms and adherence to
antiretroviral therapy (ART) among people living with HIV (PLHIV). We searched the …
antiretroviral therapy (ART) among people living with HIV (PLHIV). We searched the …
Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase …
Background Previous work established non-inferiority of switching participants who were
virologically suppressed from daily oral standard of care to monthly long-acting …
virologically suppressed from daily oral standard of care to monthly long-acting …
Long-acting parenteral drug delivery systems for the treatment of chronic diseases
The management of chronic conditions often requires patients to take daily medication for an
extended duration. However, the need for daily dosing can lead to nonadherence to the …
extended duration. However, the need for daily dosing can lead to nonadherence to the …
Doravirine/lamivudine/tenofovir disoproxil fumarate is non-inferior to efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive adults with human …
Background Doravirine (DOR), a novel non-nucleoside reverse-transcriptase inhibitor
(NNRTI), is active against wild-type Human Immunodeficiency Virus (HIV)-1 and the most …
(NNRTI), is active against wild-type Human Immunodeficiency Virus (HIV)-1 and the most …
Interventions to improve adherence to antiretroviral therapy: a rapid systematic review
Design: A rapid systematic review. Methods: We conducted a rapid systematic review of the
global evidence on interventions to improve adherence to ART, utilizing pre-existing …
global evidence on interventions to improve adherence to ART, utilizing pre-existing …
The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future
A Tseng, J Seet, EJ Phillips - British journal of clinical …, 2015 - Wiley Online Library
The evolution of human immunodeficiency virus (HIV) treatment has improved our
understanding and management of complex pharmacological issues that have driven …
understanding and management of complex pharmacological issues that have driven …
[HTML][HTML] Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy
AR Kirtane, O Abouzid, D Minahan, T Bensel… - Nature …, 2018 - nature.com
The efficacy of antiretroviral therapy is significantly compromised by medication non-
adherence. Long-acting enteral systems that can ease the burden of daily adherence have …
adherence. Long-acting enteral systems that can ease the burden of daily adherence have …
Systematic review: patient‐reported outcomes in chronic hepatitis C‐the impact of liver disease and new treatment regimens
Z Younossi, L Henry - Alimentary pharmacology & therapeutics, 2015 - Wiley Online Library
Background Treatment for chronic hepatitis C (CH‐C) is rapidly changing and moving away
from an interferon and ribavirin‐based therapy to interferon‐free ribavirin‐free all oral …
from an interferon and ribavirin‐based therapy to interferon‐free ribavirin‐free all oral …
Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001 …
F Raffi, AG Babiker, L Richert, JM Molina, EC George… - The Lancet, 2014 - thelancet.com
Background Standard first-line antiretroviral therapy for HIV-1 infection includes two
nucleoside or nucleotide reverse transcriptase inhibitors (NtRTIs), but these drugs have …
nucleoside or nucleotide reverse transcriptase inhibitors (NtRTIs), but these drugs have …